Exagen Inc. Files 2024 10-K
Ticker: XGN · Form: 10-K · Filed: Mar 11, 2025 · CIK: 1274737
| Field | Detail |
|---|---|
| Company | Exagen Inc. (XGN) |
| Form Type | 10-K |
| Filed Date | Mar 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, medical-laboratories
TL;DR
EXAGEN FILES 2024 10-K - FULL FINANCIALS OUT NOW
AI Summary
Exagen Inc. filed its 2024 10-K on March 11, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Exagen Diagnostics Inc., is based in Vista, California, and operates in the medical laboratories sector. The filing covers financial data and business operations for the period, with specific financial details to be elaborated within the full report.
Why It Matters
This 10-K filing provides a comprehensive overview of Exagen Inc.'s financial health and operational performance for the fiscal year 2024, crucial for investors and stakeholders to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — The risk level is medium as 10-K filings, while standard, contain detailed financial information that can reveal significant risks or opportunities impacting the company's valuation.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Prior Fiscal Year (For comparative financial analysis)
- 2022 — Prior Fiscal Year (For comparative financial analysis)
Key Players & Entities
- EXAGEN INC. (company) — Filer
- 20241231 (date) — Fiscal Year End
- 20250311 (date) — Filing Date
- 1261 LIBERTY WAY VISTA CA 92081 (address) — Business Address
- Exagen Diagnostics Inc. (company) — Former Company Name
FAQ
What was Exagen Inc.'s total revenue for the fiscal year ended December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ended December 31, 2024. A detailed review of the full 10-K document is required to find this information.
What is Exagen Inc.'s primary business segment?
Exagen Inc. operates in the 'SERVICES-MEDICAL LABORATORIES' sector, with SIC code 8071.
When was Exagen Inc. formerly known as Exagen Diagnostics Inc.?
The date of the name change from Exagen Diagnostics Inc. to Exagen Inc. was December 30, 2003.
What is the SEC file number for Exagen Inc.'s 10-K filing?
The SEC file number for this 10-K filing is 001-39049.
Where is Exagen Inc. headquartered?
Exagen Inc. is headquartered at 1261 Liberty Way, Vista, CA 92081.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 11, 2025 regarding EXAGEN INC. (XGN).